Call for Manuscripts

Partners in Digital Health is pleased to announce a new, annual Telehealth and Medicine Today (THMT) Call for Manuscripts specifically aimed for identifying and learning from:

Negative, Unconventional, Null, Neutral, and Failed Research

Progress in science is not only made based on positive data, but also on negative results. Scientists have become too accustomed to celebrating only success and have forgotten that most technological advances stem from failure. When negative results aren’t published in high-impact journals, other scientists can’t learn from them and end up repeating failed experiments, leading to a waste of public funds and a delay in genuine progress.

Negative results are results that do not support a research hypothesis and nullify the aim of the research. Negative, or null results, are also important because they contribute to our knowledge of the topic as much as positive results do. This is critically important in new research fields and markets that are evolving in real world applications and scaled implementations.

Understandably, researchers are particularly challenged to disclose negative results that are not consistent with previously published positive data. In addition, positive findings are more likely to generate citations and funding for additional research, but NEGATIVE DATA saves institutions funding wasteful projects and puts the ecosystem on the right track for faster solutions and outcomes that benefit the entire ecosystem.

Partners in Digital Health would like to facilitate these critical efforts to accelerate research success, augment true innovation, and create a trusted repository where research, public, and private communities can find unconventional answers to streamline meaningful solutions.

THMT will WAIVE THE APC for these manuscripts.

We know such papers are not typically cited, and discouraged in academia, however, negative results are essential to advancing knowledge in the field, and may even contribute to changing reward systems in academia in the future.

Topic areas will include but are not limited to the following:
• What and why the research did not work, eg., rigor in study design, lack of funding, issue with patient recruitment, support from superiors or colleagues, bias, etc
• Analysis of impact
• Consequences of negative research
• Lessons on mitigating negative results and why
• Benefits of sharing research
• Good research practices, best practices
• Key personal learnings
• Addressing issues of reproducibility
• Ethical violations

This list is not comprehensive. We welcome the opportunity to consider papers on related and complementary topics.

Submission Requirements
• Papers should be original submissions not previously published or under active consideration by other journal
• Papers will be 3,000 maximum word count
• Submissions must include a section for an analysis and recommendations for future researchers, and journal readers

The APC for these papers will be waived

To submit a paper, please click on the submission link below and follow instructions.

All papers will be peer reviewed and follow the journal’s peer review process and workflow.

There is no deadline for these manuscripts.

If you have questions about the suitability of a particular paper prior to submitting, please contact the managing editor, John Russo, PharmD, at or